MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, XERS has $370,191K in assets. $371,052K in debts. $91,598K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
192.79%
Quick Ratio
134.73%
Cash Ratio
78.83%
Debt to Asset Ratio
100.23%
Assets Breakdown
    • Cash and cash equivalents
    • Other assets
    • Inventory, net
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid in capital
    • Debt, net of unamortized debt is...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
91,598 59,285
Trade accounts receivable, net
53,751 53,048
Inventory, net
67,462 67,282
Prepaid expenses and other current assets
11,206 5,963
Total current assets
224,017 185,578
Property and equipment, net
4,946 5,284
Operating lease right-of-use assets
22,263 22,403
Goodwill
22,859 22,859
Other assets
90,789 93,500
Other assets
5,317 5,062
Total assets
370,191 334,686
Accounts payable
6,527 9,462
Current portion of long-term debt
0 0
Current operating lease liabilities
6,194 6,156
Other accrued liabilities
30,350 24,969
Accrued trade discounts and rebates
51,264 33,169
Accrued returns reserve
19,216 19,782
Other current liabilities
2,649 1,633
Total current liabilities
116,200 95,171
Debt, net of unamortized debt issuance costs, non-current portion
219,469 218,626
Non-current operating lease liabilities
31,991 32,441
Other liabilities
3,392 7,752
Total liabilities
371,052 353,990
Common stockpar value 0.0001, 350,000,000 shares and 350,000,000 shares authorized as of september 30, 2025 and december 31, 2024, respectively 165,528,253 and 149,429,410 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
17 16
Additional paid in capital
681,535 663,713
Accumulated deficit
-682,388 -683,009
Accumulated other comprehensive loss
-25 -24
Total stockholders' equity (deficit)
-861 -19,304
Total liabilities and stockholders' equity (deficit)
370,191 334,686
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$11,206K Inventory, net$67,462K Trade accountsreceivable, net$53,751K Cash and cashequivalents$91,598K Other assets$5,317K Other assets$90,789K Goodwill$22,859K Operating leaseright-of-use assets$22,263K Property and equipment,net$4,946K Total current assets$224,017K Total assets$370,191K Accumulated othercomprehensive loss-$25K Accumulated deficit-$682,388K Total liabilities andstockholders' equity...$370,191K Total stockholders'equity (deficit)-$861K Additional paid in capital$681,535K Common stockpar value0.0001, 350,000,000...$17K Total liabilities$371,052K Other liabilities$3,392K Non-current operating leaseliabilities$31,991K Debt, net ofunamortized debt issuance...$219,469K Total currentliabilities$116,200K Other currentliabilities$2,649K Accrued returns reserve$19,216K Accrued trade discountsand rebates$51,264K Other accruedliabilities$30,350K Current operating leaseliabilities$6,194K Accounts payable$6,527K

Xeris Biopharma Holdings, Inc. (XERS)

Xeris Biopharma Holdings, Inc. (XERS)